Skip to main content
Clinical Trials/EUCTR2015-001668-21-FR
EUCTR2015-001668-21-FRActive, not recruitingPhase 1

Addition of neuromuscular-blocking agents during induction in infants: potential interest in reducing hypoxia episodes - ROC-HYPOX

Fondation Ophtalomologique A. de Rothschild0 sites412 target enrollmentStarted: July 3, 2024Last updated:
Drugs

Trial Snapshot

Phase
Phase 1
Status
Active, not recruiting
Sponsor
Enrollment
412

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Sex
All

Inclusion Criteria

  • - Age <2 years
  • - Indication of general anesthesia with orotracheal intubation
  • - Inhalational induction scheduled
  • - Free, written and informed consent of both parents to participate in the study
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 412
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

Exclusion Criteria

  • - Contraindication to:
  • . inhalation induction (stomach full)
  • . the use of rocuronium (intubating scheduled difficult, documented allergy ...)
  • - ASA III or IV
  • - Intracranial surgery
  • - parental refusal
  • - no affiliation to French public wellfare system

Investigators

Sponsor
Fondation Ophtalomologique A. de Rothschild

Similar Trials

Addition of neuromuscular-blocking agents... | Clinical Trial